Quick Takeaways
- BAKER BROS. ADVISORS LP filed SCHEDULE 13G/A for Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share (NRIX).
- Disclosed ownership: 7.2%.
- Date of event: 31 Dec 2025.
BAKER BROS. ADVISORS LP - 31 Dec 2025 SCHEDULE 13G/A Report for Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share (NRIX)
- Filing Manager
- BAKER BROS. ADVISORS LP
- Reporting Manager
- Baker Bros. Advisors LP
- Symbol
- NRIX
- Shares outstanding
- 104,555,500 shares
- Disclosed Ownership
- 7,527,996 shares
- Ownership
- 7.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 16:16:25 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BAKER BROS. ADVISORS LP disclosed 7.2% ownership in Nurix Therapeutics, Inc. Common Stock, par value $0.001 per share (NRIX) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Feb 2026, 16:16.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 7.2% | 7,527,996 | 7,527,996 | 0 | /s/ Scott L. Lessing | Scott L. Lessing/ President By: Baker Bros. Advisors (GP) LLC, its general partner | |
| Baker Bros. Advisors (GP) LLC | 7.2% | 7,527,996 | 7,527,996 | 0 | /s/ Scott L. Lessing | Scott L. Lessing/ President | |
| Julian C. Baker | 7.2% | 7,527,996 | 7,527,996 | 0 | /s/ Julian C. Baker | Julian C. Baker | |
| Felix J. Baker | 7.2% | 7,527,996 | 7,527,996 | 0 | /s/ Felix J. Baker | Felix J. Baker |